Title(s): Professor, Director of the Clinical Trials Statistical and Data Management Center
Department: Biostatistics
Office: N511 CPHB
Phone: (319) 384-4197
Dr. Coffey is a Professor of Biostatistics and Director of the Clinical Trials Statistical and Data Management Center (CTSDMC) in the University of Iowa College of Public Health. He received his Ph.D. in biostatistics from the University of North Carolina at Chapel Hill in 1999, and has over 20 years of experience providing data management and statistical support to large randomized clinical trials. He is currently the principal investigator of the Data Coordinating Centers for the NIH funded Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) and the Statistics Core for the Michael J. Fox Foundation funded Parkinson’s Progression Markers Initiative (PPMI). Dr. Coffey has served as the primary statistician for multi-site clinical trials and biomarker studies in cryptogenic sensory peripheral neuropathy, Fragile X syndrome, glioblastoma, GNE myopathy, Huntington’s disease, hypertension, multiple sclerosis, myasthenia gravis, NMDAR encephalitis, obesity, Parkinson’s disease, spinal muscular atrophy, stroke, and traumatic brain injury. Dr. Coffey is a Fellow of the American Statistical Association, Society for Clinical Trials, and American Academy of Neurology. Dr. Coffey is a current member of the FDA Gastrointestinal Diseases Advisory committee, and serves on a number of data and safety monitoring boards. His research interests lie in the area of novel trial designs, particularly the use of adaptive designs.
Courses Taught
- Statistical Methods in Clinical Trials
- Advanced Clinical Trials
- Applied Survival and Cohort Data Analysis
Research Interests
- Linear Models
- Power Analyses
- Sample Size Re-Estimation
- Adaptive Designs
- Comparative Effectiveness Trials
Background
In the News
- Coffey shares more about his Presidential Lecture and ties to Iowa
- Coffey, Tilley to present UI’s 41st Presidential Lecture
- Survey gauges COVID-19 vaccine interest among adolescents, parents
- UI researchers seek ways to reduce opioid use, chronic pain
- CTSDMC researchers part of national effort to curb opioid use
- Iowa partnership helps neurologists design stronger clinical trials
- CTSDMC contributes to 2019 Abstract of Distinction
- Study finds drug slows brain shrinkage in people with MS
- Coffey to present CPH Distinguished Faculty Lecture Aug. 29
- Video: CTSDMC helps research move forward
- NeuroNEXT combines expertise to find treatments for neurological disorders
- CTSDMC contributes to groundbreaking neurological research through NeuroNEXT
- Pediatric migraine study selected for “Best Advances of 2017”
- CTSDMC part of potentially game-changing Parkinson’s study
- CPH, UI Health Care host national neurology clinical trial training program
- Biostat’s CHAMP study cited as one of “Best Advances of 2016”
- Pediatric migraine study named a Top Story of 2016
- CPH researchers participate in children’s migraine study
- Study compares effectiveness of preventive medicines for pediatric migraines
- Dawson, Coffey named Fellows of the American Statistical Association
- CPH Awards highlight faculty, staff achievements
- Cost-effective collaboration leads to better blood pressure
- Coffey co-author on updated stroke treatment guidelines
- Coffey helps raise awareness of MDA and ALS at Iowa Cubs game
- Coffey and Chaloner named Fellows of the Society for Clinical Trials
- CPH researchers attend meeting on Parkinson’s disease and exercise
- Clarke honored at CTSDMC’s 25th anniversary celebration